ISSN: 1859 - 2872
Update on radioiodine treatment of differentiated thyroid cancer
Main Article Content
Keywords
Differentiated thyroid cancer, radioiodine therapy I-131
Abstract
Of the thyroid cancers, thyroid carcinoma of follicular cell origin is the most common. Surgery is the initial method of choice. High-risk patients are often treated with radioiodine I-131 to reduce recurrence and prolong survival. Thyroid hormone therapy aims to replace the hormone and inhibit the growth of local or metastatic thyroid cancer cells, if present. Patients with recurrence, progressive I-131 refractory disease that cannot be treated locally, may be effective by targeted therapy in reducing progression and prolonging survival. This article aims to update related to thyroid cancer treatment with radioiodine I-131.
Article Details
References
1. Globocan (2020) Viet Nam fact sheets. https://gco.iarc.fr/today/data/factsheets/ populations/704-viet-nam-fact-sheets.pdf
2. Pacini F, Fuhrer D, Elisei R, Handkiewicz-Junak D, Leboulleux S, Luster M, Schlumberger M, Smit JW. (2022) 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? Eur Thyroid J 11(1): 210046.
3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1): 1-133.
4. NCCN. Thyroid Carcinoma. Version 3.2023. July 27, 2023.
5. Tong J, Ruan M, Jin Y, Fu H, Cheng L, Luo Q, Liu Z, Lv Z, Chen L (2022) Poorly differentiated thyroid carcinoma: a clinician's perspective. Eur Thyroid J 11(2): 220021. doi: 10.1530/ETJ-22-0021.
6. Nixon IJ, Palmer FL, Whitcher MM, Shaha AR, Shah JP, Patel SG, Ganly I (2011) Thyroid isthmusectomy for well-differentiated thyroid cancer. Ann Surg Oncol 18(3): 767-770.
7. Lee YS, Jeong JJ, Nam KH, Chung WY, Chang HS, Park CS (2010) Papillary carcinoma located in the thyroid isthmus. World J Surg 34(1): 36-39.
8. Lamartina L, Leboulleux S, Schlumberger M (2021) Thyroid cancer incidence in children and adolescents. Lancet Diabetes Endocrinol 9(3):128-129.
9. Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S (2015) American thyroid association guidelines task force. management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 25(7): 716-759.
10. Lebbink CA, Links TP, Czarniecka A, Dias RP, Elisei R, Izatt L, Krude H, Lorenz K, Luster M, Newbold K, Piccardo A, Sobrinho-Simões M, Takano T, Paul van Trotsenburg AS, Verburg FA, van Santen HM (2022) 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J 11(6): 220146.
2. Pacini F, Fuhrer D, Elisei R, Handkiewicz-Junak D, Leboulleux S, Luster M, Schlumberger M, Smit JW. (2022) 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? Eur Thyroid J 11(1): 210046.
3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1): 1-133.
4. NCCN. Thyroid Carcinoma. Version 3.2023. July 27, 2023.
5. Tong J, Ruan M, Jin Y, Fu H, Cheng L, Luo Q, Liu Z, Lv Z, Chen L (2022) Poorly differentiated thyroid carcinoma: a clinician's perspective. Eur Thyroid J 11(2): 220021. doi: 10.1530/ETJ-22-0021.
6. Nixon IJ, Palmer FL, Whitcher MM, Shaha AR, Shah JP, Patel SG, Ganly I (2011) Thyroid isthmusectomy for well-differentiated thyroid cancer. Ann Surg Oncol 18(3): 767-770.
7. Lee YS, Jeong JJ, Nam KH, Chung WY, Chang HS, Park CS (2010) Papillary carcinoma located in the thyroid isthmus. World J Surg 34(1): 36-39.
8. Lamartina L, Leboulleux S, Schlumberger M (2021) Thyroid cancer incidence in children and adolescents. Lancet Diabetes Endocrinol 9(3):128-129.
9. Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S (2015) American thyroid association guidelines task force. management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 25(7): 716-759.
10. Lebbink CA, Links TP, Czarniecka A, Dias RP, Elisei R, Izatt L, Krude H, Lorenz K, Luster M, Newbold K, Piccardo A, Sobrinho-Simões M, Takano T, Paul van Trotsenburg AS, Verburg FA, van Santen HM (2022) 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J 11(6): 220146.
Article Sidebar
Published
Sep 29, 2023
Section
Articles
How to Cite
CảnhN. X. (2023). Update on radioiodine treatment of differentiated thyroid cancer. Tạp Chí Y Dược lâm sàng 108, 18(YHHN). https://doi.org/10.52389/ydls.v18iYHHN.1916